Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | 211,684 | reported | 09 Jan 2026 | tx 156+2,390,033−787,492 |
| Prelude Therapeutics Inc | 38,000 | reported | 12 Jun 2025 | tx 10+667,302−448,370 |
| Verastem, Inc. | 25,000 | reported | 14 Jun 2016 | tx 4+97,495 |
| Sirtris Pharmaceuticals, Inc. | 22,857 | reported | 16 Apr 2008 | tx 1+22,857 |
| Dare Bioscience, Inc. | 18,819 | reported | 03 Apr 2017 | tx 7+158,033 |
| INCYTE CORP | 10,514 | reported | 26 May 2020 | tx 165+4,658,453−4,915,554 |
| Durata Therapeutics, Inc. | 0 | reported | 17 Nov 2014 | tx 4+19,720−19,720 |
| ALEXION PHARMACEUTICALS INC | 0 | reported | 21 Jul 2021 | tx 7+12,840−12,840 |
| BAUSCH & LOMB INC | 0 | reported | 26 Oct 2007 | tx 14+3,154−5,169 |
| AUXILIUM PHARMACEUTICALS INC | 0 | reported | 29 Jan 2015 | tx 40+87,649−89,958 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 280 | 15.80 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 280 | 551.24 USD | |
| 09 Jan 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 280 | 0.00 USD | deriv |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 2,450 | 517.86 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 681 | 521.03 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 840 | 521.98 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 970 | 523.00 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,199 | 524.10 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 2,432 | 525.05 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,066 | 526.00 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 1,560 | 526.97 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 575 | 528.18 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 691 | 529.17 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 166 | 529.76 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 280 | 530.69 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 532.50 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 332 | 534.16 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 148 | 535.29 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 473 | 536.02 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 487 | 536.88 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 80 | 537.85 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 480 | 539.23 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 600 | 540.36 USD | |
| 09 Jan 2026 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 40 | 545.79 USD | |
| 09 Jan 2026 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 24,520 | 15.80 USD |
7 purchases reported after at least 12 months of silence — most recent on 27 Mar 2020.